Clinical trial
Neoadjuvant Treatment of Breast Cancer - a Prospective Observational Study, PANnon ONCology (PANONC) Group Non-commercial Clinical Trial
NCT05131893 is registered in ClinicalTrials.gov with National Institute of Oncology, Hungary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neoadjuvant Treatment of Breast Cancer - a Prospective Observational Study, PANnon ONCology (PANONC) Group Non-commercial Clinical Trial
- Lead sponsor
- National Institute of Oncology, Hungary
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 31, 2022
- Completion date
- December 31, 2031
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer